相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genome-Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
Todd L. Edwards et al.
ANNALS OF HUMAN GENETICS (2010)
Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies
Andrew O. Koob et al.
EXPERIMENTAL NEUROLOGY (2010)
Lipid bilayer disruption by oligomeric alpha-synuclein depends on bilayer charge and accessibility of the hydrophobic core
Bart D. van Rooijen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer's disease
Moeko Noguchi-Shinohara et al.
BRAIN RESEARCH (2009)
Tau-Focused Immunotherapy for Alzheimer's Disease and Related Tauopathies
Einar M. Sigurdsson
CURRENT ALZHEIMER RESEARCH (2009)
Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases
Brian Spencer et al.
JOURNAL OF NEUROSCIENCE (2009)
Structural Properties of Pore-Forming Oligomers of α-Synuclein
Hai-Young Kim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Role of Synucleins in Alzheimer's Disease
Leslie Crews et al.
NEUROTOXICITY RESEARCH (2009)
Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy
Maria Xilouri et al.
PLOS ONE (2009)
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Paula Desplats et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
α-synuclein degradation by autophagic pathways -: A potential key to Parkinson's disease pathogenesis
Maria Xilouri et al.
AUTOPHAGY (2008)
Clearance and deposition of extracellular α-synuclein aggregates in microglia
He-Jin Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Membrane binding of oligomeric α-synuclein depends on bilayer charge and packing
Bart D. van Rooijen et al.
FEBS LETTERS (2008)
Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein
He-Jin Lee et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
Igor F. Tsigelny et al.
PLOS ONE (2008)
Origins and effects of extracellular alpha-synuclein: Implications in Parkinson's disease
Seung-Jae Lee
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Transgenic animal models of neurodegenerative diseases and their application to treatment development
Edward Rockenstein et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
An investigation into the lipid-binding properties of α-, β- and γ-synucleins in human brain and cerebrospinal fluid
Sultan A. Salem et al.
BRAIN RESEARCH (2007)
Dynamics of α-synuclein aggregation and inhibition of pore-like oligomer development by β-synuclein
Igor F. Tsigelny et al.
FEBS JOURNAL (2007)
Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies
Michael L. Kramer et al.
JOURNAL OF NEUROSCIENCE (2007)
Conformational properties of the SDS-bound state of R-synuclein probed by limited proteolysis: Unexpected rigidity of the acidic C-terminal tail
Patrizia Polverino de Laureto et al.
BIOCHEMISTRY (2006)
Clearance and prevention of prion infection in cell culture by anti-PrP antibodies
Joanna Pankiewicz et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
The Parkinson's complex: Parkinsonism is just the tip of the iceberg
JW Langston
ANNALS OF NEUROLOGY (2006)
Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: Lessons from mice, monkeys, and humans
CA Lemere et al.
REJUVENATION RESEARCH (2006)
Neural activity controls the synaptic accumulation of α-synuclein
DL Fortin et al.
JOURNAL OF NEUROSCIENCE (2005)
β-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease
M Buttini et al.
JOURNAL OF NEUROSCIENCE (2005)
Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies
WJ Wolfgang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Intravesicular localization and exocytosis of α-synuclein and its aggregates
HJ Lee et al.
JOURNAL OF NEUROSCIENCE (2005)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
WX Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A beta Immunotherapy: Lessons Learned for Potential Treatment of Alzheimer's Disease
Dale B. Schenk et al.
NEURODEGENERATIVE DISEASES (2005)
Inhibiting aggregation of α-synuclein with human single chain antibody fragments
S Emadi et al.
BIOCHEMISTRY (2004)
Morphological characterization of thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Aβ immunotherapy on their clearance
T Bussière et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy
AM Cuervo et al.
SCIENCE (2004)
Impact of the acidic C-terminal region comprising amino acids 109-140 on α-synuclein aggregation in vitro
W Hoyer et al.
BIOCHEMISTRY (2004)
A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed α-synuclein
C Zhou et al.
MOLECULAR THERAPY (2004)
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
EJ Benner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
α-Synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells:: role in the pathogenesis of Parkinson's disease
M Hashimoto et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Neurodegenerative disease - Amyloid pores from pathogenic mutations
HA Lashuel et al.
NATURE (2002)
Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Early formation of mature amyloid-β protein deposits in a mutant APP transgenic model depends on levels of Aβ1-42
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
E Masliah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
α-Synuclein and the Lewy body disorders
DW Dickson
CURRENT OPINION IN NEUROLOGY (2001)
Spectrum of Parkinson's disease, Parkinson's dementia, and lewy body dementia
IG McKeith et al.
NEUROLOGIC CLINICS (2000)
Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
R Borghi et al.
NEUROSCIENCE LETTERS (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
